National Gilles De La Tourette Study Group
Sponsor
Groupe Hospitalier Pitie-Salpetriere (Other)
Overall Status
Unknown status
CT.gov ID
NCT00169351
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France (Other)
1
Study Details
Study Description
Brief Summary
Tourette syndrome is rare. In France, about 3000 patients have a severe form of the disease. The aim of this study is to collect clinical characteristics in 200 patients with Tourette syndrome.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Observational Model:
Defined Population
Time Perspective:
Prospective
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
15 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Tourette syndrome
Exclusion Criteria:
- severe cognitive disorders
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Centre d'Investigation Clinique-HÔPITAL PITIÉ-SALPETRIERE | Paris | France |
Sponsors and Collaborators
- Groupe Hospitalier Pitie-Salpetriere
- Institut National de la Santé Et de la Recherche Médicale, France
Investigators
- Study Director: Yves Agid, MD, PhD, Groupe Hospitalier Pitié-Salpêtrière
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00169351
Other Study ID Numbers:
- RBM0418
First Posted:
Sep 15, 2005
Last Update Posted:
Sep 15, 2005
Last Verified:
Sep 1, 2005
Additional relevant MeSH terms: